Baptist Clinical Research Institute

The trials here

What the 18 trials at this site are about, from their registry records.

Conditions

• Lung cancer11 trials
• Acute lymphoblastic leukaemia2 trials
• Sarcoma2 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Kidney cancer1 trial
• Mantle cell lymphoma1 trial
• Myelodysplastic syndromes1 trial
• and 3 more

Phase

• Phase 36 trials
• Phase 24 trials
• Phase 1/22 trials
• Phase 2/31 trial

Status

• Recruiting8 trials
• Active, not recruiting5 trials
• Completed3 trials
• Terminated1 trial
• Withdrawn1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Median Technologies2 trials
• Takeda2 trials
• Actuate Therapeutics Inc.1 trial
• AVM Biotechnology Inc1 trial
• and 10 more

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Pfizer· Source

• Recruiting

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· Phase 3· Kura Oncology, Inc.· Source

• Recruiting

  Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

  NCT06745882· Phase 2· H. Lee Moffitt Cancer Center and Research Institute· Source

  Contact: Osarenren Ogbeide, MD (principal investigator)

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

  NCT06196008· City of Hope Medical Center· Source

  Contact: Jane Zhao, MD

• Active, not recruiting

  CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

  NCT05306288· Delfi Diagnostics Inc.· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· Phase 3· Gilead Sciences· Source

• Recruiting

  The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  NCT04329728· Phase 1/2· AVM Biotechnology Inc· Source

  Contact: Salil Goorha

• Active, not recruiting

  A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

  NCT04302025· Phase 2· Genentech, Inc.· Source

• Recruiting

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

  NCT04419649· Phase 2· Takeda· Source

  Contact: Muhammad Raza (principal investigator)

• Active, not recruiting

  9-ING-41 in Patients With Advanced Cancers

  NCT03678883· Phase 2· Actuate Therapeutics Inc.· Source

• Recruiting

  International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  NCT03151629· Prostate Cancer Clinical Trials Consortium· Source

  Contact: Osarenren Ogbeide, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer4 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mantle cell lymphoma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting

Closed trials

• Recruiting

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· Phase 3· Takeda· Source

• Completed

  Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD

  NCT06751576· Median Technologies· Source

• Completed

  Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

  NCT06576232· Median Technologies· Source

• Terminated

  SPARK-ALL: Calaspargase Pegol in Adults With ALL

  NCT04817761· Phase 2/3· Institut de Recherches Internationales Servier· Source

• Completed

  Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

  NCT03583086· Phase 1/2· Vanderbilt-Ingram Cancer Center· Source